Menu
Recruiting NCT07456436

Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials

— Observational Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Non-Interventional Study.
Who it may be relevant to
Registry conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm. Basic parameters: from 21 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This study assesses patient awareness and understanding of cancer clinical trials.

Detailed description

PRIMARY OBJECTIVE:

I. To develop a multi-level data-driven intervention to improve cancer patient engagement with cancer clinical trials.

OUTLINE: This is an observational study.

Patients review educational materials and complete surveys on study.

Interventions

  • Other Non-Interventional Study
    Non-interventional study

Primary outcome measures

  • Change in Baseline Survey Score [Time frame: Through study completion, up to 1 year]

Eligibility criteria

Inclusion criteria

  • Eligible patient participants will be:
  • Black/African American, Asian/Asian American, White or Hispanic adults of any gender 21 years of age or older. Race/ethnicity will be self-reported
  • Have been diagnosed any cancer type

Exclusion criteria

  • Participants (patients) will be excluded if they:
  • Are unable to give informed consent
  • Are unable to speak English or Spanish

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

United States · 1 center
  • USC / Norris Comprehensive Cancer Center — Los Angeles

Identifiers

NCT: NCT07456436 · 19PS-24-2 · NCI-2026-00806 · 19PS-24-2 · P30CA014089

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗